A little lower on the NPAT side that I thought would be the case... but still, the reaction has been severe. At < 10*P/E and still a yield of ~6.8% (albeit unfranked), I don't see how this isn't a go-er...
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025